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The unmasking of a Brugada phenotype after pulmonary resection:
A case report and implications for postoperative management
Saila P. Nicotera, MD, MPH, Min P. Kim, MD, and Malcolm M. Decamp, MD, Boston, Massachusetts
The unmasking of latent arrhythmogenic diseases after gen-
eral thoracic surgery has, to date, not been described. We
present a patient in whom a Brugada pattern became evident
on electrocardiogram after pulmonary resection.
CLINICAL SUMMARY
A 78-year-old white man was diagnosed with non–small
cell lung cancer by transthoracic fine-needle aspirate. His
medical history included type I diabetes mellitus, hypothy-
roidism, emphysema, and a distant history of cholangiocar-
cinoma treated with surgery, chemotherapy, and radiation.
He had a 30-pack-year smoking history and stopped using
tobacco 20 years ago.
Staging evaluation, including magnetic resonance imag-
ing of the brain, positron emission tomography-computed
tomography scan, flexible bronchoscopy, and mediastino-
scopy, revealed node-negative poorly differentiated stage
IA non–small cell lung cancer. The patient enrolled in a clin-
ical trial studying the efficacy of pre-resection administra-
tion of amiodarone in reducing postoperative atrial
dysrhythmias. As part of the study protocol 7 days before
his operation, the patient commenced taking 200 mg of
amiodarone orally twice per day. He underwent an uncom-
plicated left thoracotomy and left lower lobectomy, and con-
tinued to receive oral amiodarone the day after his operation.
Pain control was achieved using epidural anesthesia, with
the catheter positioned at the T4 level. The epidural solution
consisted of 0.1% bupivacaine and 10 mg/mL of hydromor-
phone, infused from 4 to 6 mL/h.
The patient’s postoperative course was complicated by oli-
guria, azotemia, hyperglycemia, and hyperkalemia. Blood
urea nitrogen and serum creatinine levels increased to 39
and 1.8 mg/dL from baseline values of 22 and 0.9 mg/dL, re-
spectively. Peak serum potassium level was measured at 6.1
mg/dL. On discovery of hyperkalemia, an electrocardiogram
was obtained to assess for electrolyte-related changes.
‘‘Cove’’-type ST elevations and a right bundle branch block
were noted in precordial leads V1 and V2. Known as the Bru-
gada syndrome pattern, these findings were vastly different
from the patient’s preoperative electrocardiogram (Figures
1 and 2).
A medication review was undertaken. Any medications
known to block cardiac sodium channels were identified
and discontinued. The hyperkalemia was corrected. Serial
cardiac enzymes failed to reveal an acute ischemic event.
A transthoracic echocardiogram showed a mildly dilated
left atrium, normal regional left ventricular wall motion,
a left ventricular ejection fraction of more than 55%, and
trivial mitral regurgitation. Compared with the patient’s
preoperative study, the echocardiogram was unchanged.
Serial electrocardiograms were obtained, and 48 hours after
the Brugada pattern was noted, the electrocardiogram
normalized.
Throughout the period of electrocardiographic abnormal-
ity, our patient remained asymptomatic. He denied any his-
tory of syncope or near-syncope. His family history was
negative for sudden cardiac death. He recovered from sur-
gery and was discharged on the sixth postoperative day.
DISCUSSION
Brugada syndrome is a rare inherited arrhythmogenic dis-
ease linked to sudden cardiac death, known to be caused
most often by mutation of the SCN5A gene located on chro-
mosome 3p. The gene locus codes for a sodium channel pro-
tein, and the loss-of-function mutation results in decreased
sodium conduction across the channel. Drugs causing so-
dium channel blockade further reduce channel conduction,
precipitating an often fatal dysrhythmia through a reentrant
phenomenon.
Several factors have been reported to unmask a latent Bru-
gada electrocardiogram pattern, including fever, electrolyte
disturbances, and various pharmacologic agents.1 A number
of these factors were relevant to our patient. He was receiving
bupivacaine via epidural anesthesia. There is 1 case report in
the literature in which bupivacaine was postulated to have
unmasked a Brugada pattern.2
There is 1 recent report in the English language literature
of amiodarone inducing a Brugada pattern during the acute
intravenous phase of infusion.3 Ours is the first known report
of the association of oral amiodarone with unmasking the
Brugada pattern. Amiodarone slows cardiac conduction
via blockade of sodium channels and may be the mechanism
by which the phenotype is exposed. Hyperkalemia has been
cited as potentially inducing Brugada syndrome, and our pa-
tient did have elevated serum potassium levels.4
Supraventricular dysrhythmias are a common complica-
tion after both cardiac and general thoracic surgery. Our
case report is the first known description in the English
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Brief CommunicationsFIGURE 1. Brugada phenotype is unmasked after pulmonary resection.language literature of an unmasked inherited arrhythmo-
genic phenotype occurring after pulmonary resection.
Some 40% to 60% of idiopathic ventricular fibrillation
cases are attributed to Brugada syndrome alone and bear
no reflection on other inherited arrhythmogenic genotypes,
such as the long QT syndromes.5 Knowing that dysrhyth-
mias are common after thoracic surgery raises the possibil-
ity that some unexplained cases of postoperative death
may be attributable to unmasking a latent arrhythmogenic
phenotype.
CONCLUSIONS
The 12-lead electrocardiogram is a critical component to
the comprehensive care of the patient after cardiothoracic
surgery. In addition to the correction of electrolyte abnor-
malities and the exclusion of an ischemic event, latent in-1594 The Journal of Thoracic and Cardiovascularherited arrhythmogenic disease should be considered when
new postoperative electrocardiogram changes are seen. A
better understanding of their mechanism and knowledge of
medications that can unmask the syndrome could improve
postoperative outcomes after cardiac and pulmonary
surgery.
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